Drawing upon the expertise of more than 300 researchers and
clinicians from the Schools of Medicine, Engineering and Humanities
& Sciences, the Stanford Cancer Institute is at the forefront of
today's advances in cancer research and medicine.
Interdisciplinary research by Stanford experts in cancer biology,
epidemiology and other fields is yielding critical insights into the
origins of cancer, while collaborations between the lab and clinic are
working to move the most promising discoveries into improved
diagnostic, treatment and prevention strategies.
Patients seeking care at Stanford may gain early access to these
emerging therapies-and the benefits that they may offer-through the
center's clinical trials program.
This video explains how Stanford doctors use the genetics of individual tumors to design a personalized treatment for best results and to guide development of new treatments.
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.